This compound, identified as [2-({4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino)ethoxy]sulfonic acid, is a known impurity of hydroxychloroquine sulfate. It is structurally characterized as a sulfonic acid derivative of a hydroxychloroquine-related metabolite or degradation product, featuring the core 7-chloro-4-aminoquinoline scaffold with an extended alkylamino side chain terminated by a sulfonic acid group. Its primary and definitive application is within the pharmaceutical quality control and analytical chemistry sectors. It serves as a reference standard or impurity standard for the analysis of hydroxychloroquine drug substances and finished products. Accurate identification and quantification of this impurity are critical for ensuring drug safety, efficacy, and compliance with regulatory guidelines (e.g., ICH Q3A/B) during the manufacturing and shelf-life monitoring of hydroxychloroquine. While structurally complex, its use is highly specialized and not as a general-purpose synthetic building block. Therefore, its classification is firmly rooted in its role as a pharmaceutical impurity reference material, directly supporting drug development and quality assurance processes.